Can B Corp
Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website… Read more
Can B Corp (CANB) - Net Assets
Latest net assets as of September 2024: $-9.79 Million USD
Based on the latest financial reports, Can B Corp (CANB) has net assets worth $-9.79 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.86 Million) and total liabilities ($11.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-9.79 Million |
| % of Total Assets | -527.31% |
| Annual Growth Rate | N/A |
| 5-Year Change | -115.74% |
| 10-Year Change | -1113.97% |
| Growth Volatility | 197.44 |
Can B Corp - Net Assets Trend (2010–2023)
This chart illustrates how Can B Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Can B Corp (2010–2023)
The table below shows the annual net assets of Can B Corp from 2010 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-1.00 Million | -137.14% |
| 2022-12-31 | $2.70 Million | -51.99% |
| 2021-12-31 | $5.62 Million | +72.60% |
| 2020-12-31 | $3.26 Million | -48.86% |
| 2019-12-31 | $6.37 Million | +82.47% |
| 2018-12-31 | $3.49 Million | +301.68% |
| 2017-12-31 | $-1.73 Million | -236.17% |
| 2016-12-31 | $-514.59K | -614.66% |
| 2015-12-31 | $99.99K | +1.18% |
| 2014-12-31 | $98.82K | +60.88% |
| 2013-12-31 | $61.42K | +76.90% |
| 2012-12-31 | $34.72K | -97.06% |
| 2011-12-31 | $1.18 Million | +775.01% |
| 2010-12-31 | $-174.70K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Can B Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9774011600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $83.26 Million | % |
| Other Comprehensive Income | $119.59K | % |
| Other Components | $18.04 Million | % |
| Total Equity | $-1.00 Million | 100.00% |
Can B Corp Competitors by Market Cap
The table below lists competitors of Can B Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Loop Energy Inc.
PINK:LPENF
|
$2.15 Million |
|
GENMAB - Dusseldorf Stock Exchang
DU:GE9
|
$2.15 Million |
|
CIBOX INTER. NOM. EO -02
F:1YH
|
$2.15 Million |
|
Sixty Six Capital Inc
OTCQB:HYHDF
|
$2.15 Million |
|
OCEAN SKY INTL
F:O3S1
|
$2.15 Million |
|
Purebread Brands Inc.
V:BRED
|
$2.15 Million |
|
Akbar Indomakmur Stimec Tbk
JK:AIMS
|
$2.15 Million |
|
YLI Holdings Bhd
KLSE:7014
|
$2.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Can B Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 2,697,925 to -1,001,968, a change of -3,699,893 (-137.1%).
- Net loss of 9,737,464 reduced equity.
- Other factors increased equity by 6,037,571.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-9.74 Million | -971.83% |
| Other Changes | $6.04 Million | +602.57% |
| Total Change | $- | -137.14% |
Book Value vs Market Value Analysis
This analysis compares Can B Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | $-1493.16 | $0.03 | x |
| 2011-12-31 | $33.51 | $0.03 | x |
| 2012-12-31 | $0.89 | $0.03 | x |
| 2013-12-31 | $1.56 | $0.03 | x |
| 2014-12-31 | $2.50 | $0.03 | x |
| 2015-12-31 | $2.10 | $0.03 | x |
| 2016-12-31 | $-9.85 | $0.03 | x |
| 2017-12-31 | $-30.38 | $0.03 | x |
| 2018-12-31 | $37.04 | $0.03 | x |
| 2019-12-31 | $46.38 | $0.03 | x |
| 2020-12-31 | $13.82 | $0.03 | x |
| 2021-12-31 | $4.18 | $0.03 | x |
| 2022-12-31 | $0.76 | $0.03 | x |
| 2023-12-31 | $-0.08 | $0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Can B Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -451.70%
- • Asset Turnover: 0.21x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-743.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 0.00% | -4877.56% | 0.78x | 0.00x | $-1.10 Million |
| 2011 | -97.48% | -55612.72% | 0.00x | 1.18x | $-1.27 Million |
| 2012 | -4776.63% | -6883.54% | 0.09x | 7.81x | $-1.66 Million |
| 2013 | -521.78% | -1959.51% | 0.09x | 2.93x | $-326.64K |
| 2014 | -26.91% | -81.64% | 0.12x | 2.74x | $-36.47K |
| 2015 | -3848.95% | -3734.76% | 0.72x | 1.43x | $-3.86 Million |
| 2016 | 0.00% | -698.99% | 0.69x | 0.00x | $-613.59K |
| 2017 | 0.00% | -1743.21% | 0.56x | 0.00x | $-1.97 Million |
| 2018 | -117.87% | -615.06% | 0.18x | 1.06x | $-4.46 Million |
| 2019 | -72.14% | -199.20% | 0.33x | 1.09x | $-5.23 Million |
| 2020 | -175.58% | -334.36% | 0.30x | 1.75x | $-6.04 Million |
| 2021 | -216.56% | -264.33% | 0.28x | 2.93x | $-12.73 Million |
| 2022 | -553.17% | -223.23% | 0.43x | 5.77x | $-15.19 Million |
| 2023 | 0.00% | -451.70% | 0.21x | 0.00x | $-9.64 Million |
Industry Comparison
This section compares Can B Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Can B Corp (CANB) | $-9.79 Million | 0.00% | N/A | $2.15 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |